MedTrace Logo

An Innovative Mental Health Virtual Ward: Evaluation of Patient-Centered Outcomes

NCT06526026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-08-06

No results posted yet for this study

Summary

The goal of this study is to evaluate if admission to the Mental Health Virtual Ward (MH vWard) for mental health crisis stabilization is having a meaningful positive impact on patient reported outcomes and healthcare utilization. The objectives of this study are:

1. Prospectively measure demographic, recovery, service delivery, and systems use outcomes in a cohort of MH vWard admissions.
2. establish this cohort for use in future research.

As part of the intervention, participants will receive care in the MH vWard for an average of 5 days following a visit to an emergency department or crisis centre for a mental health crisis. While admitted to the MH vWard, participants will:

1. Engage in individual therapy and care planning with a clinician or psychiatry team.
2. Have engagement with formal (community providers) and informal supports (family, friends) for collateral and collaboration.
3. Receive medication reconciliation and management.
4. Participate in group programming.
5. Receive referrals for follow-up services.
6. Have access to after hours support.
7. Have access to the Telus Home Health Monitoring (HHM) App, which is custom designed to complement the services provided by the program.

Conditions

  • Mental Health Disorder
  • Mental Health Impairment
  • Psychiatric Emergency
  • Crisis; Emotional

Interventions

BEHAVIORAL

Virtual crisis stabilization support with a multi-disciplinary team

Daily 1:1 sessions with multidisciplinary team via a range of virtual modalities (videoconferencing, phone, text, email), group programming, self-management resources, remote home monitoring app, referrals and linkages to community programs.

Sponsors & Collaborators

  • Health Sciences Centre Foundation, Manitoba

    collaborator OTHER

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Jennifer Hensel, MD · University of Manitoba and Shared Health Manitoba/Psychiatry

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-22
Primary Completion
2025-07-29
Completion
2025-07-29

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526026 on ClinicalTrials.gov